Effect of FGFR3 activity on Nectin-4 expression in urothelial carcinoma

被引:0
|
作者
Clark-Garvey, Sean
Zhou, Mi
Truong, Andrew
Beckabir, Wolfgang
Sturdivant, Michael
Kim, William
机构
关键词
D O I
10.1158/1538-7445.AM2023-4867
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4867
引用
收藏
页数:2
相关论文
共 50 条
  • [1] FGFR inhibition upregulates Nectin-4 expression in FGFR3 altered urothelial carcinoma
    Clark-Garvey, Sean
    Zhou, Mi
    Sturdivant, Michael
    Beckabir, Wolfgang
    Kim, Lucia
    Toomer, E. Drew
    McCabe, Ian
    Hamada, Akihiro
    Crona, Daniel
    Damrauer, Jeffrey S.
    Kim, William Y.
    CLINICAL CANCER RESEARCH, 2024, 30 (10)
  • [2] PATTERN OF EXPRESSION AND MUTATION STATUS OF FGFR2/3 AND NECTIN-4 IN UROTHELIAL CARCINOMA
    Inamoto, Teruo
    Komura, Kazumasa
    Uehara, Hirofumi
    Uchimoto, Taizo
    Saito, Kenkichi
    Tanda, Naoki
    Matsunaga, Tomohisa
    Ichihashi, Atsushi
    Tsutsumi, Takeshi
    Tsujino, Takuya
    Yoshikawa, Yuki
    Takai, Tomoaki
    Minami, Koichiro
    Taniguchi, Shunri
    Ibuki, Naokazu
    Hirano, Hajime
    Nomi, Hayahito
    Azuma, Haruhito
    JOURNAL OF UROLOGY, 2020, 203 : E1008 - E1008
  • [3] Variable Expression of Nectin-4 in Bladder Urothelial Carcinoma with Divergent Differentiation
    Lombardo, Kara
    Choi, Woonyoung
    McGuire, Bridget
    Parimi , Vamsi
    Kamanda, Sonia
    Matoso, Andres
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 581 - 582
  • [4] Variable Expression of Nectin-4 in Bladder Urothelial Carcinoma with Divergent Differentiation
    Lombardo, Kara
    Choi, Woonyoung
    McGuire, Bridget
    Parimi , Vamsi
    Kamanda, Sonia
    Matoso, Andres
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 581 - 582
  • [5] The biology and rationale of targeting nectin-4 in urothelial carcinoma
    Heath, Elisabeth I.
    Rosenberg, Jonathan E.
    NATURE REVIEWS UROLOGY, 2021, 18 (02) : 93 - 103
  • [6] The biology and rationale of targeting nectin-4 in urothelial carcinoma
    Elisabeth I. Heath
    Jonathan E. Rosenberg
    Nature Reviews Urology, 2021, 18 : 93 - 103
  • [7] Expression of Nectin-4 in Bladder Urothelial Carcinoma, in Morphologic Variants, and Nonurothelial Histotypes
    Hoffman-Censits, Jean H.
    Lombardo, Kara A.
    Parimi, Vamsi
    Kamanda, Sonia
    Choi, Woonyoung
    Hahn, Noah M.
    McConkey, David J.
    McGuire, Bridget M.
    Bivalacqua, Trinity J.
    Kates, Max
    Matoso, Andres
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2021, 29 (08) : 619 - 625
  • [8] Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts
    Bahlinger, Veronika
    Branz, Annalena
    Strissel, Pamela L.
    Strick, Reiner
    Lange, Fabienne
    Geppert, Carol, I
    Kluemper, Niklas
    Hoelzel, Michael
    Wach, Sven
    Taubert, Helge
    Sikic, Danijel
    Wullich, Bernd
    Angeloni, Miriam
    Ferrazzi, Fulvia
    Diehl, Lauri
    Kovalenko, Maria
    Elboudwarej, Emon
    Juergensmeier, Juliane M.
    Hartmann, Arndt
    Eckstein, Markus
    HISTOPATHOLOGY, 2024, 84 (05) : 863 - 876
  • [9] FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder
    Guancial, Elizabeth A.
    Werner, Lillian
    Bellmunt, Joaquim
    Bamias, Aristotle
    Choueiri, Toni K.
    Ross, Robert
    Schutz, Fabio A.
    Park, Rachel S.
    O'Brien, Robert J.
    Hirsch, Michelle S.
    Barletta, Justine A.
    Berman, David M.
    Lis, Rosina
    Loda, Massimo
    Stack, Edward C.
    Garraway, Levi A.
    Riester, Markus
    Michor, Franziska
    Kantoff, Philip W.
    Rosenberg, Jonathan E.
    CANCER MEDICINE, 2014, 3 (04): : 835 - 844
  • [10] Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts.
    Bahlinger, Veronika
    Branz, Annalena
    Strissel, Pamela
    Strick, Reiner
    Lange, Fabienne
    Geppert, Carol-Immanuel
    Kluemper, Niklas
    Hoelzel, Michael
    Wach, Sven
    Taubert, Helge
    Sikic, Danijel
    Wullich, Bernd
    Angeloni, Miriam
    Ferrazzi, Fulvia
    Diehl, Lauri
    Kovalenko, Maria
    Elboudwarej, Emon
    Juergensmeier, Juliane Margarete
    Hartmann, Arndt
    Eckstein, Markus
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41